Metabolic aspects of the use of medium chain triglycerides in the treatment of obesity.
D000328:Adult; D001786:Blood Glucose; D001794:Blood Pressure / Q000187:drug effects; D003611:Dairy Products; D004038:Diet, Reducing; D005215:Fasting; D005227:Fatty Acids / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006801:Humans; D007657:Ketone Bodies / Q000097:blood; D008297:Male; D008875:Middle Aged; D009584:Nitrogen / Q000378:metabolism / Q000652:urine; D009765:Obesity / Q000188:drug therapy* / Q000378:metabolism; D010101:Oxygen Consumption / Q000187:drug effects; D010743:Phospholipids / Q000097:blood; D005082:Physical Exertion; D011674:Pulse / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D014280:Triglycerides / Q000627:therapeutic use*; D014692:Ventilation-Perfusion Ratio / Q000187:drug effects
D001786:Blood Glucose; D005227:Fatty Acids; D005230:Fatty Acids, Nonesterified; D007657:Ketone Bodies; D010743:Phospholipids; D014280:Triglycerides; D009584:Nitrogen